ARCHIVES

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

This article is from The Cancer Letter archive.

Vol. 21 No. 07 | February 17, 1995

Download PDF Visit The Full Archive

Related Articles

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

Senate Confirms Elias Zerhouni For NIH Director

May 3, 2002

Black Physicians, Community Group To work With NCI

April 21, 1989

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002